BTX Quote, Trading Chart, BioTime Inc.
$15.34 Last:
-1.54% Change Percent:
$15.76 Open:
$15.34 Previous Close:
$16.4 High:
$15.24 Low:
3,275,412 Volume:
06/17/2021 04:44:37 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
BTX Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-06-17 | 15.76 | 15.34 | 16.4 | 15.24 | 3,275,412 |
| 2021-06-16 | 14.74 | 15.58 | 16.4599 | 14.5 | 4,145,533 |
| 2021-06-15 | 15.04 | 14.91 | 15.2899 | 14.26 | 1,842,558 |
| 2021-06-14 | 15.65 | 15.22 | 17.45 | 14.95 | 6,915,134 |
| 2021-06-11 | 14.62 | 14.3 | 15.03 | 14.21 | 1,433,352 |
| 2021-06-10 | 14.9 | 14.75 | 15.15 | 14.14 | 1,924,695 |
| 2021-06-09 | 15.9 | 14.96 | 16.23 | 14.85 | 3,017,996 |
| 2021-06-08 | 15.05 | 15.53 | 16.6345 | 14.901 | 4,331,379 |
| 2021-06-07 | 16.61 | 15.03 | 16.75 | 14.801 | 3,504,251 |
| 2021-06-04 | 18.57 | 16.25 | 19.4 | 16.0201 | 3,892,371 |
| 2021-06-03 | 18.99 | 18.84 | 21.68 | 18.3 | 5,153,649 |
| 2021-06-02 | 17.18 | 20.3 | 20.38 | 16.75 | 9,522,103 |
| 2021-06-01 | 14.48 | 16.63 | 16.98 | 14.48 | 7,185,570 |
| 2021-05-31 | 14.47 | 14.4 | 15.05 | 13.81 | 2,655,399 |
| 2021-05-28 | 14.47 | 14.4 | 15.05 | 13.81 | 2,623,531 |
| 2021-05-27 | 13.73 | 14.49 | 15.885 | 13.58 | 6,999,635 |
| 2021-05-26 | 13.98 | 13.68 | 14.87 | 13.5 | 4,222,257 |
| 2021-05-25 | 16.22 | 14.66 | 17.82 | 14.42 | 16,429,479 |
| 2021-05-24 | 13.92 | 16.97 | 17.95 | 13.32 | 25,520,996 |
| 2021-05-21 | 16.53 | 13.99 | 16.95 | 13.9 | 5,070,687 |
News, Short Squeeze, Breakout and More Instantly...
-
Shares of Brooklyn ImmunoTherapeutics (NYSEMKT: BTX) , no stranger to sharp stock price movements lately, zoomed more than 6% higher on Monday. The catalyst was an acquisition announced that morning by the clincial-stage biotech company. In a joint press release, Brooklyn and No...
-
NEW YORK, June 14, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics LLC (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood disorders, and monogenic ...
-
BROOKLYN, N.Y., June 09, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics , Inc. (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood disorders, and m...